196 related articles for article (PubMed ID: 32661677)
1. Nuclear magnetic resonance and surface-assisted laser desorption/ionization mass spectrometry-based serum metabolomics of kidney cancer.
Nizioł J; Ossoliński K; Tripet BP; Copié V; Arendowski A; Ruman T
Anal Bioanal Chem; 2020 Sep; 412(23):5827-5841. PubMed ID: 32661677
[TBL] [Abstract][Full Text] [Related]
2. Nuclear magnetic resonance and surface-assisted laser desorption/ionization mass spectrometry-based metabolome profiling of urine samples from kidney cancer patients.
Nizioł J; Ossoliński K; Tripet BP; Copié V; Arendowski A; Ruman T
J Pharm Biomed Anal; 2021 Jan; 193():113752. PubMed ID: 33197834
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic and elemental profiling of human tissue in kidney cancer.
Nizioł J; Copié V; Tripet BP; Nogueira LB; Nogueira KOPC; Ossoliński K; Arendowski A; Ruman T
Metabolomics; 2021 Mar; 17(3):30. PubMed ID: 33661419
[TBL] [Abstract][Full Text] [Related]
4. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
[TBL] [Abstract][Full Text] [Related]
5. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
6. Human Melanoma-Cell Metabolic Profiling: Identification of Novel Biomarkers Indicating Metastasis.
Kosmopoulou M; Giannopoulou AF; Iliou A; Benaki D; Panagiotakis A; Velentzas AD; Konstantakou EG; Papassideri IS; Mikros E; Stravopodis DJ; Gikas E
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244549
[TBL] [Abstract][Full Text] [Related]
7. Targeted and untargeted urinary metabolic profiling of bladder cancer.
Ossoliński K; Ruman T; Copié V; Tripet BP; Kołodziej A; Płaza-Altamer A; Ossolińska A; Ossoliński T; Nieczaj A; Nizioł J
J Pharm Biomed Anal; 2023 Sep; 233():115473. PubMed ID: 37229797
[TBL] [Abstract][Full Text] [Related]
8. A proton nuclear magnetic resonance-based metabonomics study of metabolic profiling in immunoglobulin a nephropathy.
Sui W; Li L; Che W; Guimai Z; Chen J; Li W; Dai Y
Clinics (Sao Paulo); 2012; 67(4):363-73. PubMed ID: 22522762
[TBL] [Abstract][Full Text] [Related]
9. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.
Dawiskiba T; Deja S; Mulak A; Ząbek A; Jawień E; Pawełka D; Banasik M; Mastalerz-Migas A; Balcerzak W; Kaliszewski K; Skóra J; Barć P; Korta K; Pormańczuk K; Szyber P; Litarski A; Młynarz P
World J Gastroenterol; 2014 Jan; 20(1):163-74. PubMed ID: 24415869
[TBL] [Abstract][Full Text] [Related]
10. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.
Liu Y; Hong Z; Tan G; Dong X; Yang G; Zhao L; Chen X; Zhu Z; Lou Z; Qian B; Zhang G; Chai Y
Int J Cancer; 2014 Aug; 135(3):658-68. PubMed ID: 24382646
[TBL] [Abstract][Full Text] [Related]
11. Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: application to the detection of breast cancer.
Gu H; Pan Z; Xi B; Asiago V; Musselman B; Raftery D
Anal Chim Acta; 2011 Feb; 686(1-2):57-63. PubMed ID: 21237308
[TBL] [Abstract][Full Text] [Related]
12. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
[No Abstract] [Full Text] [Related]
13. Metabolomic profiling of human bladder tissue extracts.
Ossoliński K; Ruman T; Copié V; Tripet BP; Kołodziej A; Płaza-Altamer A; Ossolińska A; Ossoliński T; Krupa Z; Nizioł J
Metabolomics; 2024 Jan; 20(1):14. PubMed ID: 38267657
[TBL] [Abstract][Full Text] [Related]
14. Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods.
Zhang J; Bowers J; Liu L; Wei S; Gowda GA; Hammoud Z; Raftery D
PLoS One; 2012; 7(1):e30181. PubMed ID: 22291914
[TBL] [Abstract][Full Text] [Related]
15. Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study.
Cox IJ; Aliev AE; Crossey MM; Dawood M; Al-Mahtab M; Akbar SM; Rahman S; Riva A; Williams R; Taylor-Robinson SD
World J Gastroenterol; 2016 Apr; 22(16):4191-200. PubMed ID: 27122669
[TBL] [Abstract][Full Text] [Related]
16. Differentiation between sepsis survivors and sepsis non-survivors through blood serum metabolomics: A proton nuclear magnetic resonance spectroscopy (NMR) study.
Naveen Kumar MS; Gupta G; Kumar V; Jagannathan NR; Sinha S; Mewar S; Kumar P
Magn Reson Imaging; 2022 Jun; 89():49-57. PubMed ID: 35176448
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Multivariate Classification Models for Analyzing NMR Metabolomics Data.
Vu T; Siemek P; Bhinderwala F; Xu Y; Powers R
J Proteome Res; 2019 Sep; 18(9):3282-3294. PubMed ID: 31382745
[TBL] [Abstract][Full Text] [Related]
18. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
19. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
